HoffmanGM, RossGA, DaySE, RiceTB, NelinLD. Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygen-ation in persistent pulmonary hypertension of the newborn. Crit Care Med1997;25:352–359.
2.
MassaroAF, GastonB, KitaD, FantaC, StamlerJS, DrazenJM. Expired nitric oxide levels during treatment of acute asthma. Am J Respir Crit Care Med1995;152(2):800–803.
3.
MassaroAF, MehtaS, LillyCM, KobzikL, ReillyJJ, DrazenJM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med1996;153(5):1510–1514.
4.
KharitonovSA, ChungKF, EvansD, O'ConnorBJ, BarnesPJ. In-creased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract. Am J Respir Crit Care Med1996;153(6 Pt 1):1773–1780.
5.
BaraldiE, AxxolinNM, ZanconatoS, DarioC, ZacchelloF, Corti-costeriodsdecrease exhaled nitric oxide in children with acute asthma. J Pediatr1997;131(3):423–427.
6.
LanzMJ, LeungDY, McCormickDR, HarbeckR, SzeflerSJ, WhiteCW. Comparison of exhaled nitric oxide, serum eosinophilic cation in protein, and soluable interleukin-2 receptor in exacerbations of pediatric asthma. Pediatr Pulmonol1997;24(5):305–311.
7.
NelsonBV, SearsS, WoodsJ, LingCY, HuntJ, ClapperLM, et al. Expired nitric oxide as a marker for childhood asthma. J Pediatr1997;130(3):423–427.
8.
de GouwHW, HendricksJ, WoltmanAM, TwissIM, SterkPJ. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstric-tion to direct and indirect stimuli in asthma. Am J Respir Crit Care Med1998;158(1):315–319.
9.
ZoritchB.Nitric oxide and asthma. Arch Dis Child1995;72(3):259–262.
10.
BelvisiMS, StrettonCD, YacoubM, BarnesPJ. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans. Eur J Pharmacol1992;210(2):221–222.
11.
DupuyPM, ShoreSA, DrazenJM, FrostellC, HillWA, ZapolW.Bronchodilator action of inhaled nitric oxide in guinea pigs. J Clin Invest1992;90(2):421–428.
12.
KacmarekRM, RippleR, CockrillBA, BlochKJ, ZapolWM, John-sonDC. Inhaled nitric oxide: a bronchodilator in mild asthmatics with methacholine-induced bronchospasm. Am J Respir Crit Care Med1996;153(1):128–135.
13.
PfefferKD, EllisonG, RobertsonD, DayRW. The effect of inhaled nitric oxide in pediatric asthma. Am J Respir Crit Care Med1996;153(2):747–751.
14.
DavisSL, FurmanDP, CastorinaAT. Adult respiratory distress syn-drome in children: associated disease, clinical course, and predictors of death. J Pediatr1993;123:35–45.
15.
PaulsonTE, SpearRM, PetersonBM. New concepts in the treatment of children with acute respiratory distress syndrome. J Pediatr1995;127(2):163–175.
16.
RoyallJA, LevinDL. Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathol-ogy, and mechanisms of lung injury. J Pediatr1988;112(2):129–180.
17.
TimmonsOD, DeanJM, VernonDD. Mortality rates and prognostic variables in children with adult respiratory distress syndrome. J Pe-diatr1991;119(6):896–899.
18.
HeulittM, FacklerJ, GreenT, SteinhartC, NicholsD, WareJ, FiserD.Morbidity in survivors of pediatric acute respiratory distress syn-drome: a multicenter study (abstract). Am J Respir Crit Care Med1997;155:A503.
19.
AbmanSH, GriebelJL, ParkerDK, SchmidtJM, SwantonD, Kin-sellaJP. Acute effects of inhaled nitric oxide in children with severe hypoxemic respiratory failure. J Pediatr1994;124(6):881–888.
20.
DayRW, GuarinM, LynchJM, VernonDD, DeanJM. Inhaled nitric oxide in children with severe lung disease: results of acute and prolonged therapy with two concentrations. Crit Care Med1996;24(2):215–221.
21.
DayRW, AllenEM, WitteMK. A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure. Chest1997;112(5):1324–1331.
22.
DemirakcaS, DotschJ, KnotheC, MagsaamJ, ReiterHL, BauerJ, KuehlPG. Inhaled nitric oxide in neonatal and pediatric acute re-spiratory distress syndrome: dose response, prolonged inhalation, and weaning. Crit Care Med1996;24(11):1913–1919.
23.
GermainJF, MercierJC, CasadevallI, DesplanquesL, HartmannJF, BeaufilsF.Is there a role for inhaled nitric oxide in pediatric ARDS?Pediatr Pulmonol Suppl1995;11:110–112.
24.
GoldmanAP, TaskerRC, HosiassonS, HenrichsenT, MacraeDJ. Early response to inhaled nitric oxide and its relationship to outcome in children with severe hypoxemic respiratory failure. Chest1997;112(3):752–758.
25.
NakagawaTA, MorrisA, GomezRJ, JohnstonSJ, SharkeyPT, ZaritskyAL. Dose response to inhaled nitric oxide in pediatric pa-tients with pulmonary hypertension and acute respiratory distress syndrome. J Pediatr1997;131(1 Pt 1):63–69.
26.
BancalariE, GerhardtT.Bronchopulmonary dysplasia. Pediatr Clin N Amer1986;33(1):1–23.
27.
GoldbertRN, BancalariE.Bronchopulmonary dysplasia: clinical presentation and the role of mechanical ventilation. Respir Care1986;31(7):591–598.
28.
LonnqvistPA, JonssonB, WinbergP, FrostellCG. Inhaled nitric oxide in infants with developing or established chronic lung disease. Acta Paediatr1995;84(2):1188–1192.
29.
ThompsonMW, BatesJN, KleinJM. Treatment of respiratory fail-ure with bronchopulmonary dysplasia infected with respiratory syn-cytial virus using inhaled nitric oxide and high frequency ventilation. Acta Paediatr1995;84(1):100–102.
30.
AtzAM, WesselDL. Inhaled nitric oxide in sickle cell disease with acute chest syndrome. Anesthesiology1997;87(4):988–990.
31.
WesselDL, AdatiaI.Clinical applications of inhaled nitric oxide in children with pulmonary hypertension. Adv Pharmacol1995;34:475–504.
32.
WesselDL, AdatiaI, GigliaTM, ThompsonJE, KulikTJ. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation1993;88(5 Pt 1):2128–2138.
33.
AdatiaI, LilleheiC, ArnoldJH, ThompsonJE, PalazzoR, FacklerJC, WesselDL. Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation. Ann Thorac Surg1994;57(5):1311–1318.
34.
AdatiaI, PerryS, LandzbergM, MooreP, ThompsonJE, WesselDL. Inhaled nitric oxide and hemodynamic evaluation of patients with pulmonary hypertension before transplantation. J Am Coll Car-diol1995;25(7):1656–1664.
35.
SnellGI, SalamonsenRF, BerginP, EsmoreDS, KhanS, WilliamsTJ. Inhaled nitric oxide used as a bridge to heart-lung transplantation in a patient with end-stage pulmonary hypertension. Am J Respir Crit Care Med1995;151(4):1263–1266.
